GLOBAL STEM CELL MARKET FORECAST 2017-2025

  • You are here:
  • Home
  • Reports
  • GLOBAL STEM CELL MARKET FORECAST 2017-2025

GLOBAL STEM CELL MARKET FORECAST 2017-2025

The Global Stem cell market is expected to grow from $ 48675 million in 2016 to $377902 million by 2025, at a CAGR of 25.76% between 2017 and 2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The global rise in neurodegenerative diseases is creating scope to the stem cell market.

The Global Stem cell market is expected to grow from $ 48675 million in 2016 to $377902 million by 2025, at a CAGR of 25.76% between 2017 and 2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The global rise in neurodegenerative diseases is creating scope to the stem cell market. Neurodegenerative diseases are the set of conditions which chiefly affect the neurons present in the human brain.

The Regenerative medicine applications are expected to dominate the Global Stem Cell market. Regenerative medicine market is growing due to private and government support for the development of regenerative medicines, growing incidence of chronic disease and genetic disorder, growing healthcare expenditure across the world, and rising aging population. The Drug discovery and development is anticipated to grow at a faster rate. Drug discovery and development is expected to grow at a CAGR of 26.59%. Regenerative medicines have the capability to return the lost functionality of organs or tissues, not like conventional medicines that are palliative. Drug development is a process of carrying a pharmaceutical drug to market, once a major compound is identified by the process of drug discovery. It also includes pre-clinical research on animals and microorganisms, filing for regulatory statutes, such as the United States Food and Drug Administration for the investigational new drug to start a clinical trial on human, and include the step of getting regulatory approval with new drug application to the drug market.

Stem Cell Market

Adult Stem Cell market is expected to lead the Global Stem Cell Market in terms of Product usage whereas the Induced Pluripotent market is anticipated to grow at a significant CAGR of 31.75%. Adult stem cells are widely utilized in therapeutic applications such as the development of regenerative medicines, for the treatment of leukemia with the help of bone marrow transplantation, tissue engineering etc.Human embryonic stem cells bear a capability to derive the cells of all tissue of adult organisms and adult stem cells that are more specialized in functions.Induced pluripotent stem cells contain those cells that are inaccessible from blood or skin and reprogrammed to an embryonic-like pluripotent state that is utilized further for the development of several types of human cells for therapeutic purpose.Rat neural stem cells are multipotent and can be utilized in the generation of astrocytes, neurons, and oligodendrocytes.  Applications of rat neural cells include neural cell-based therapies for degenerative diseases such as dementia, Alzheimer disease etc., the study of human neural development and transplantation strategies of neural diseases and development of therapies related to neural injuries.

The Stem Cell market in North America is expected to hold the largest share by 2025. Possibilities of revolutionizing the way the chronic conditions are being treated that includes degenerative diseases, a majority of which still do not have effective treatments and only a few real treatments presently available. North America held the largest market share of the global Stem Cell Market. The expanding investments across research and development activities for the stem cell market and the presence of the popular pharmaceutical market have contributed to the expanding share of the US market in the North American region. Asia- Pacific is anticipated to grow at CAGR of 26.23%, the fastest growing region among others. The growth of Asia-Pacific region is primarily driven due to growing incidences of chronic lifestyle diseases and government supports and their initiatives. Europe has generated a revenue of $13556 million in 2016 which is set to increase by 2025. The Europe stem cell analysis market is primarily driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders.

The upsurge in Neurodegenerative Ailments, Investments in R&D Is Growing, Government Subsidy and Sustenance, Advancements in the application of Stem Cell, Significant Growth In Medical Tourism, Swelling Stem Cell Banking are the major drivers for the Stem Cell market. R&D investment in stem cell researchers are increasing as there is a huge potential in the market and thus, large and small companies are focusing this market. Conversely, factors inhibiting the market growth are Stem Cell Treatment Incurs Huge Cost, Aversion in Reimbursement Policies. Rising investment in the stem cell market and the government funding for research and development of stem cell are driving the market. Government laws and rules for the stem cell therapy and research are creating a burden in the growth of stem cell market. Different countries use different government policies for the use of stem cell for treatment and research purpose. These laws are the source of many controversies.

Major players for the Stem Cell market are Cytori Therapeutics Inc., Fibrocell Science, Cellartis AB (acquired by Takara Holdings Inc.), Biotime Inc., GE Healthcare, Thermo Fisher scientific Pvt Ltd, Stem cell technologies, Cellular Dynamics international (holding company Fujifilm), Vericel Corporation (Aastrom Bioscience), Brainstorm cell therapeutics, California stem cell Inc. (Holding company Caladrius biosciences, Inc. ), Beckton Dickinson and company, Stryker Corporation, Celgene Corporation. Some major companies involved in stem cell are; GE Healthcare, Stem cell technology, Thermo Fisher, Becton, Corning and many others. All these contribute to more than 40% of the total market revenue. The majority of such companies are focusing toward the product launches in the stem cell.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • ESTIMATION METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET DEFINITION AND SCOPE
    • KEY FINDINGS
  4. MARKET DETERMINANTS
    • MARKET DRIVER
      • UPSURGE IN NEURODEGENERATIVE AILMENTS
      • INVESTMENTS IN R&D IS GROWING
      • GOVERNMENT SUBSIDY AND SUSTENANCE
      • ADVANCEMENTS IN THE APPLICATIONS OF STEM CELL
      • SIGNIFICANT GROWTH IN MEDICAL TOURISM
      • SWELLING STEM CELL BANKING
    • MARKET RESTRAINTS
      • STEM CELL TREATMENT INCURS HUGE COST
      • AVERSION IN REIMBURSEMENT POLICIES
    • MARKET OPPORTUNITIES
      • RISING INVESTMENT IN THE STEM CELL MARKET
      • REPLACED THE USE OF ANIMAL TISSUES FOR THE EXPERIMENTS
      • GROWING INCOME OF THE PEOPLE ALL ACROSS THE WORLD
      • CONTINUE SUPPORT OF CONTRACT RESEARCH INDUSTRY
    • MARKET CHALLENGES
      • STRINGENT GOVERNMENT REGULATIONS
      • FEWER RESPONSIVENESS IN THE DEVELOPED ECONOMIES
  1. MARKET SEGMENTATION
    • BY PRODUCTS
      • ADULT STEM CELL MARKET
        • HEMATOPOIETIC STEM CELL MARKET
        • MESENCHYMAL STEM CELL MARKET
        • NEURAL STEM CELL MARKET
        • DENTAL STEM CELL MARKET
        • UMBILICAL CORD STEM CELL MARKET
      • HUMAN EMBRYONIC STEM CELL
      • INDUCED PLURIPOTENT STEM CELL MARKET
      • RAT NEURAL STEM CELL MARKET
    • BY TECHNOLOGY
      • STEM CELL ACQUISITION MARKET
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS MARKET
        • STEM CELL UMBILICAL CORD BLOOD MARKET
      • STEM CELL PRODUCTION MARKET
        • THERAPEUTIC CLONING FOR STEM CELL MARKET
        • IVF STEM CELL MARKET
        • STEM CELL CULTURE MARKET
      • STEM CELL CRYOPRESERVATION MARKET
      • STEM CELLS EXPANSION AND SUB-CULTURE MARKET
    • STEM CELLS MARKET BY APPLICATION
      • STEM CELLS REGENERATIVE MEDICINE MARKET
      • DRUG DISCOVERY AND DEVELOPMENT MARKET
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • PESTEL ANALYSIS
    • VALUE CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
    • KEY BUYING CRITERIA
      • HIGH PRICE
      • EFFICANCY
      • APPLICATION AND EFFECTIVENESS
      • ACCURACY
    • STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
    • VENDOR LANDSCAPE
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA STEM CELL MARKET
      • UNITED STATES (U.S.) STEM CELL MARKET
      • CANADA STEM CELL MARKET
    • EUROPE STEM CELL MARKET
      • UNITED KINGDOM (UK) STEM CELL MARKET
      • FRANCE STEM CELL MARKET
      • GERMANY STEM CELL MARKET
      • SPAIN STEM CELL MARKET
      • ITALY STEM CELL MARKET
      • ROE STEM CELL MARKET
    • ASIA-PACIFIC STEM CELL MARKET
      • INDIAN STEM CELL MARKET
      • CHINA STEM CELL MARKET
      • JAPAN STEM CELL MARKET
      • KOREA STEM CELL MARKET
      • REST OF APAC STEM CELL MARKET
    • REST OF THE WORLD (ROW) STEM CELL MARKET
      • LATIN AMERICA STEM CELL MARKET
      • MENA STEM CELL MARKET
      • AFRICA STEM CELL MARKET
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
  1. COMPANY PROFILE
    • CYTORI THERAPEUTICS INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • FIBROCELL SCIENCE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • CELLARTIS AB (ACQUIRED BY TAKARA HOLDINGS INC.)
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • BIOTIME INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • GE HEALTHCARE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • THERMO FISHER SCIENTIFIC PVT. LTD
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • STEMCELL TECHNOLOGIES
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • VERICEL CORPORATION (AASTROM BIOSCIENCE)
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • BRAINSTORM CELL THERAPEUTICS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • CALIFORNIA STEM CELL INC. (HOLDING COMPANY CALADRIUS BIOSCIENCES, INC )
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGICINITIATIVES
      • SCOT ANALYSIS
      • STRATEGICANALYSIS
    • BECKTON DICKINSON AND COMPANY
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • STRYKER CORPORATION
      • OVERVIEW
      • PRODUCTPORTFOLIO
      • SCOT ANALYSIS
      • STRATEGICANALYSIS
    • CORNING INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • CELGENE CORPORATION
      • OVERVIEW
      • PRODUCTPORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS

 

TABLE LIST

TABLE # 1 COUNTRY WISE PERCENTAGE OF SAVINGS IN STEM CELL TREATMENT

TABLE # 2 GLOBAL STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)

TABLE # 3 ADULT STEM CELL MARKET BY REGION 2017-2025 ($ MILLION)

TABLE # 4 ADULT STEM CELL MARKET 2017-2025 ($ MILLION)

TABLE # 5 GLOBAL STEM CELL MARKET IN HEMATOPOITIC STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 6 GLOBAL STEM CELL MARKET IN MESENCHYMAL STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 7 GLOBAL STEM CELL MARKET IN NEURAL STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 8 GLOBAL STEM CELL MARKET IN DENTAL STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 9 GLOBAL STEM CELL MARKET IN UMBILICAL CORD STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 10 GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 11 GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 12 GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL BY REGION 2017-2025 ($ MILLION)

TABLE # 13 GLOBAL STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)

TABLE # 14 GLOBAL STEM CELL ACQUISITION MARKET 2017-2025 ($ MILLION)

TABLE # 15 GLOBAL STEM CELL ACQUISITION MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 16 STEM CELL BONE MARROW MARKET BY REGIONS 2017-2025 ($ MILLION)

TABLE # 17 GLOBAL STEM CELL APHERESIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 18 GLOBAL STEM CELL UMBLICAL CORD BLOOD MARKET BY REGIONS 2017-2025 ($ MILLION)

TABLE # 19 GLOBAL STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)

TABLE # 20 GLOBAL STEM CELL PRODUCTION MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 21 GLOBAL STEM CELL THERAPEUTIC CLONING MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 22 GLOBAL IVF STEM CELL MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 23 GLOBAL STEM CELL CULTURE MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 24 GLOBAL STEM CELL CRYOPRESERVATION MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 25 GLOBAL STEM CELL EXPANSION AND SUB-CULTURE MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 26 GLOBAL STEM CELLS MARKET BY APPLICATION 2017-2025 ($ MILLION)

TABLE # 27 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 28 NEW CANCER CASES BY SEX, US, 2016

TABLE # 29 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 30 GLOBAL STEM CELL MARKET BY REGION 2017-2025($ MILLION)

TABLE # 31 NORTH AMERICA STEM CELL MARKET 2017-2025 ($ MILLION)

TABLE # 32 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)

TABLE # 33 ASIA-PACIFIC STEM CELL MARKET 2017-2025 ($ MILLION)

TABLE # 34 INDIAN HEALTH DISORDERS IN 2016 (%)

TABLE # 35 ROW STEM CELL MARKET BY REGIONS 2017-2025 ($ MILLION)

 

FIGURES LIST       

FIGURE # 1 GLOBAL STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 2 GLOBAL STEM CELL MARKET BY REGION 2017-2025 ($ MILLION)

FIGURE # 3 KEY FINDINGS OF STEM CELL MARKET

FIGURE # 4 AGES OF PEOPLE WITH ALZHEIMER’S DISEASE IN THE UNITED STATES, 2016

FIGURE # 5 NIH SPENDING ON STEM CELL RESEARCH BY YEAR 2013-2016 IN USD $BILLION

FIGURE # 6 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)

FIGURE # 7 US DISPOSABLE PERSONAL INCOME IN USD BILLIONS

FIGURE # 8 GLOBAL STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)

FIGURE # 9 GLOBAL STEM CELLS MARKET IN ADULT STEM CELL 2017-2025 ($ MILLION)

FIGURE # 10 GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)

FIGURE # 11 GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)

FIGURE # 12 GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)

FIGURE # 13 GLOBAL STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)

FIGURE # 14 GLOBAL STEM CELL MARKET BY ACQUISITION 2017-2025 ($ MILLION)

FIGURE # 15 GLOBAL STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)

FIGURE # 16 GLOBAL STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)

FIGURE # 17 GLOBAL STEM CELL UMBLICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)

FIGURE # 18 GLOBAL STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)

FIGURE # 19 GLOBAL STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)

FIGURE # 20 GLOBAL IVF STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 21 GLOBAL STEM CELLS CULTURE MARKET 2017-2025 ($ MILLION)

FIGURE # 22 GLOBAL STEM CELLS CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)

FIGURE # 23 GLOBAL STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)

FIGURE # 24 GLOBAL STEM CELLS MARKET BY APPLICATION 2017 & 2025 ($ MILLION)

FIGURE # 25 GLOBAL STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)

FIGURE # 26 GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)

FIGURE # 27 GEOGRAPHIC OUT LOOK 2016 & 2025 (%)

FIGURE # 28 TOP GROWING COUNTRIES 2017-2025 ($ MILLION)

FIGURE # 29 ESTIMATED NUMBER OF NOVEL CANCER CASES AND DEATHS BY GENDER IN THE U.S., 2016

FIGURE # 30 NORTH AMERICA STEM CELL MARKET BY COUNTRIES 2016 & 2025 ($ MILLION)

FIGURE # 31 NORTH AMERICA STEM CELL REGIONAL MARKET BREAKDOWN IN 2016 (%)

FIGURE # 32 UNITED STATES (U.S.) STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 33 ESTIMATED CASES OF CANCER IN CANADA 2015

FIGURE # 34 CANADA STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 35 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 36 EUROPE STEM CELL MARKET REGIONAL OUTLOOK 2016 & 2025 %)

FIGURE # 37 UNITED KINGDOM (UK) STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 38 FRANCE STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 39 AGE STRUCTURE OF GERMANY 2015

FIGURE # 40 POPULATION AGED ABOVE 65 YEARS 2005 & 2015 (% OF POPULATION)

FIGURE # 41 GERMANY STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 42 SPAIN STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 43 ITALY STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 44 ROE STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 45 ASIA-PACIFIC STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 46 INDIAN STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 47 LUNG CANCER STATISTICS IN CHINA (2010 & 2015)

FIGURE # 48CHINA STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 49 JAPAN STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 50 KOREA STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 51 REST OF APAC STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 52 LATIN AMERICA STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 53 MENA STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 54 AFRICA STEM CELL MARKET 2017-2025 ($ MILLION)

FIGURE # 55 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)

  1. MARKET SEGMENTATION
    • BY PRODUCTS
      • ADULT STEM CELL MARKET
        • HEMATOPOIETIC STEM CELL MARKET
        • MESENCHYMAL STEM CELL MARKET
        • NEURAL STEM CELL MARKET
        • DENTAL STEM CELL MARKET
        • UMBILICAL CORD STEM CELL MARKET
      • HUMAN EMBRYONIC STEM CELL
      • INDUCED PLURIPOTENT STEM CELL MARKET
      • RAT NEURAL STEM CELL MARKET
    • BY TECHNOLOGY
      • STEM CELL ACQUISITION MARKET
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS MARKET
        • STEM CELL UMBILICAL CORD BLOOD MARKET
      • STEM CELL PRODUCTION MARKET
        • THERAPEUTIC CLONING FOR STEM CELL MARKET
        • IVF STEM CELL MARKET
        • STEM CELL CULTURE MARKET
      • STEM CELL CRYOPRESERVATION MARKET
      • STEM CELLS EXPANSION AND SUB-CULTURE MARKET
    • STEM CELLS MARKET BY APPLICATION
      • STEM CELLS REGENERATIVE MEDICINE MARKET
      • DRUG DISCOVERY AND DEVELOPMENT MARKET
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA STEM CELL MARKET
      • UNITED STATES (U.S.) STEM CELL MARKET
      • CANADA STEM CELL MARKET
    • EUROPE STEM CELL MARKET
      • UNITED KINGDOM (UK) STEM CELL MARKET
      • FRANCE STEM CELL MARKET
      • GERMANY STEM CELL MARKET
      • SPAIN STEM CELL MARKET
      • ITALY STEM CELL MARKET
      • ROE STEM CELL MARKET
    • ASIA-PACIFIC STEM CELL MARKET
      • INDIAN STEM CELL MARKET
      • CHINA STEM CELL MARKET
      • JAPAN STEM CELL MARKET
      • KOREA STEM CELL MARKET
      • REST OF APAC STEM CELL MARKET
      • REST OF THE WORLD (ROW) STEM CELL MARKET
      • LATIN AMERICA STEM CELL MARKET
      • MENA STEM CELL MARKET
      • AFRICA STEM CELL MARKET

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.